Characterization of a novel metabolic strategy used by drug-resistant tumor cells.
Harper ME, Antoniou A, Villalobos-Menuey E, Russo A, Trauger R, Vendemelio M, George A, Bartholomew R, Carlo D, Shaikh A, Kupperman J, Newell EW, Bespalov IA, Wallace SS, Liu Y, Rogers JR, Gibbs GL, Leahy JL, Camley RE, Melamede R, Newell MK.
FASEB J. 2002 Oct;16(12):1550-7.PMID: 12374777 [PubMed - indexed for MEDLINE]Related articlesFree article